LMDXF — LumiraDx Share News
0.000.00%
Last trade - 00:00- $1.64m
- $378.94m
- $254.48m
LumiraDx up as UK health agency approves COVID-19, RSV tests
Brief: LumiraDx Receives UK CTDA Approval For COVID Ultra, COVID & RSV Tests
U.S.-listed shares of LumiraDx slump on fall in revenue
LumiraDx Ltd reports results for the quarter ended in March - Earnings Summary
Brief: LumiraDx Reports First Quarter 2023 Results
LumiraDx Ltd expected to post a loss of 14 cents a share - Earnings Preview
LumiraDx Ltd expected to post a loss of 14 cents a share - Earnings Preview
Brief: Lumiradx Ltd Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
U.S. STOCKS ON THE MOVE-Bath & Body Works, Buckle, Levi Strauss
U.S. STOCKS ON THE MOVE-YUM! Brands, LumiraDx, Clean Energy Tech
LumiraDx gains on more job cuts
Brief: LumiraDx Announces Strategic Refocus And Cost Restructuring Program
LumiraDx Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Lumiradx Reports Fourth Quarter And Full Year 2022 Results
LumiraDx Ltd expected to post a loss of 20 cents a share - Earnings Preview
Brief: Lumiradx Regains Compliance With Nasdaq Continued Listing Requirements
U.S. STOCKS ON THE MOVE-Fat Brands, Spotify, Uber Tech
U.S. STOCKS ON THE MOVE-Apple, PayPal, Pinterest